Risk of thromboembolism and fatal stroke in patients with psoriasis and nonvalvular atrial fibrillation: a Danish nationwide cohort study

By  

JOURNAL OF INTERNAL MEDICINE, Vol. 277, Iss. 4, 2015-04 ,pp. : 447-455

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Phase II, double‐blind, randomized, parallel group, dose‐finding study of the safety and tolerability of darexaban compared with warfarin in patients with non‐valvular atrial fibrillation: the oral factor Xa inhibitor for prophylaxis of stroke in atrial fibrillation study 2 (OPAL‐2)

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 8, 2015-08 ,pp. : 1405-1413

John Wiley & Sons Inc

Access to resources Recommend Favorite

Beyond Prediction of Stroke Risk in Nonvalvular Atrial Fibrillation

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 63, Iss. 6, 2015-06 ,pp. : 1284-1285

John Wiley & Sons Inc

Access to resources Recommend Favorite

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

By Heidbuchel Hein   Verhamme Peter   Alings Marco   Antz Matthias   Hacke Werner   Oldgren Jonas   Sinnaeve Peter   Camm A. John   Kirchhof Paulus  

EP-Europace, Vol. 15, Iss. 5, 2013-05 ,pp. : 625-651

Oxford University Press

Access to resources Recommend Favorite

Effects of Aspirin and Clopidogrel versus Oral Anticoagulation on Platelet Function and on Coagulation in Patients with Nonvalvular Atrial Fibrillation (CLAFIB)

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 1, 2002-05 ,pp. : 16-24

Karger

Access to resources Recommend Favorite